[A case of recurrent esophageal cancer with tracheal invasion treated by chemo-radiotherapy (CRT) after placement of tracheal stent that maintained complete response (CR) for two years]

Gan To Kagaku Ryoho. 2010 Nov;37(12):2331-3.
[Article in Japanese]

Abstract

Frequently advanced or recurrent esophageal cancer was invasive trachea and often causing hemoptysis, stenosis and dyspnea. Occasionally, these cases were treated by a placement of tracheal stent. The placement effect was quickly and a main symptom of dyspnea was improved dramatically. However, the most of the cases were in poor prognosis with advanced cancer treated by chemo-radiotherapy (CRT). We experienced a case of recurrent esophageal cancer with tracheal invasion treated by placement of tracheal expandable metallic stent (EMS). A case was a 73-year-old man (at first admission). He was performed esophagectomy with tracheotomy against esophageal carcinoma at cervical portion. Eighteen month later, a local recurrence with tracheal invasion was appeared. The tracheal covered stent was inserted at the recurrent site. After stenting, CRT was performed with 5-FU and docetaxel. The effect of CRT was complete response (CR). Hence, a stent was removed from trachea. No recurrence was observed at the site and maintained a CR condition for two years after CRT.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Combined Modality Therapy
  • Docetaxel
  • Esophageal Neoplasms / pathology*
  • Esophageal Neoplasms / therapy*
  • Fluorouracil / administration & dosage
  • Humans
  • Male
  • Neoplasm Invasiveness / pathology
  • Neoplasm Recurrence, Local
  • Remission Induction
  • Stents*
  • Taxoids / administration & dosage
  • Trachea / pathology*
  • Tracheal Neoplasms / pathology
  • Tracheal Neoplasms / therapy*
  • Tracheal Stenosis / therapy

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Taxoids
  • Docetaxel
  • Fluorouracil